APOE and Cognitive impairment: Hence, to assess the relationship between cognition and FC alterations in our presented framework we examined the association between FC and cognitive performance in two groups: cognitively healthy, CSF Aβ42/40-negative, APOE ε4 non-carriers (N = 310) and individuals with mild cognitive impairment (MCI) or AD dementia (N = 258).